Barr Tamoxifen Sales Benefit From Zeneca's Risk Reduction Campaign
Barr's tamoxifen sales increased by more than one-third in the third quarter of fiscal 1999, Barr CEO Bruce Downey said during an April 21 conference call.
Barr's tamoxifen sales increased by more than one-third in the third quarter of fiscal 1999, Barr CEO Bruce Downey said during an April 21 conference call.